Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (5632)	9/22/1998 12:27:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 9719

Rocketman--do you have anything to add to your post long ago, I linked to it today on the xoma thread Message 5809724 It seemed like a good one to grab now so that I have one potential anti-angiogenesis in my basket, especially now that the chart has seemed to have made a bottom. I realize Neuprex may be too good to be true, and posts like 5388 on this thread are just the sort of thing that newbies like me get suckered in on, but what the heck. While I'm on that thought, without getting another debate going on the subject, Rick, if you're lurking here today, what exactly did your comments about rBPI-21&3 awhile back mean? Different topic: Thread: Why is the portfolio riding gztc down? quote.yahoo.com maybe it will get a bounce along with the other Genzyme seedlings? but still no bottom in sight. If that thing makes a bottom during tax loss selling season will you double down (that is when I plan to buy it back). Noticed a few of the larger cap stocks were doing well, agph and genz got recommendations? The microcap biotechs seem to be getting a little help as biggies like bgen, amgn etc head higher, not that I'm ready to dump my Fidelity Select money into fbiox yet, he he, that's the kind of thing you do when the market makes a bottom, which isn't going to happen til dow 6000, imho. --MM